Coherus Oncology, Inc. Leases Disclosure
10.Leases
The Company leases approximately 27,532 square feet of office space for its corporate headquarters in Redwood City, California under a lease agreement that expires in September 2027. The Company also leases approximately 25,017 square feet for its laboratory facilities in Camarillo, California. This lease commenced in January 2020, terminates in and contains a -time option to extend the lease term for five years. Both facility leases provide for certain limited rent abatement and annual scheduled rent increases over their respective lease terms.
The Company determined that the above facility leases were operating leases. No options to extend the lease terms were included as part of the right-of-use assets or lease liabilities as it was not reasonably certain the Company would exercise those options.
Supplemental information related to the Company’s operating leases is as follows:
(in thousands) | December 31, | |||||||
Assets | | Balance Sheet Classification | | 2025 | 2024 | |||
Operating leases | $ | 2,953 | $ | 4,518 | ||||
Total leased assets | $ | 2,953 | $ | 4,518 | ||||
Liabilities | ||||||||
Operating lease liabilities, current | $ | 1,828 | $ | 1,691 | ||||
Operating lease liabilities, non-current | 1,457 | 3,286 | ||||||
Total operating lease liabilities | $ | 3,285 | $ | 4,977 | ||||
Other information related to lease term and discount rate for our operating leases is as follows:
December 31, | ||||
Operating leases | | 2025 | 2024 | |
Weighted-Average Remaining Lease Term | 1.7 years | 2.7 years | ||
Weighted-Average Discount Rate | 12.1% | 11.9% | ||
The components of lease expense were as follows:
Year Ended December 31, | ||||||||
(in thousands) | 2025 | | 2024 | |||||
Finance lease cost | | | ||||||
Amortization of right-of-use assets | $ | — | | $ | 225 | |||
Interest on lease liabilities | — | 24 | ||||||
Total finance lease cost | — | | 249 | |||||
Operating lease cost | | | 2,066 | | 2,066 | |||
Total lease cost | | | 2,066 | | 2,315 | |||
Less: Finance lease cost from discontinued operations | — | (210) | ||||||
Total lease cost from continuing operations | $ | 2,066 | $ | 2,105 | ||||
Supplemental cash flow information related to leases was as follows:
Year Ended December 31, | ||||||||
(in thousands) | 2025 | | 2024 | |||||
Cash paid for amounts included in measurement of lease liabilities: | ||||||||
Operating cash flows from operating leases | | $ | 2,192 | | $ | 2,095 | ||
Operating cash flows from finance leases | $ | — | $ | 24 | ||||
Financing cash flows from finance leases | $ | — | $ | 248 | ||||
As of December 31, 2025, the maturities of the lease liabilities were as follows:
Year ending December 31, (in thousands) | Operating leases | ||
2026 | $ | 2,126 | |
2027 |
| 1,530 | |
Total lease payments |
| 3,656 | |
Less: Imputed interest |
| (371) | |
Lease liabilities | $ | 3,285 | |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 9, 2026 | Showing above |
| 2024 | Mar 17, 2025 | |
| 2023 | Mar 15, 2024 | |
| 2022 | Mar 6, 2023 | |
| 2021 | Feb 23, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 27, 2020 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.